Carderock Capital Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-17,171
| Closed | -$3.38M | – | 89 |
|
|
2023
Q1 | $3.38M | Sell |
17,171
-210
| -1% | -$43.2K | 1.18% | 46 |
|
|
2022
Q4 | $3.52M | Sell |
17,381
-71
| -0.4% | -$13.9K | 1.46% | 34 |
|
|
2022
Q3 | $3.07M | Sell |
17,452
-3,995
| -19% | -$818K | 1.57% | 26 |
|
|
2022
Q2 | $4.32M | Sell |
21,447
-1,605
| -7% | -$342K | 1.8% | 24 |
|
|
2022
Q1 | $5.22M | Sell |
23,052
-9,161
| -28% | -$2.15M | 1.69% | 25 |
|
|
2021
Q4 | $8.7M | Buy |
32,213
+1,809
| +6% | +$448K | 2.09% | 18 |
|
|
2021
Q3 | $7.35M | Sell |
30,404
-142
| -0.5% | -$35.8K | 2.07% | 16 |
|
|
2021
Q2 | $7.24M | Buy |
30,546
+147
| +0.5% | +$33.5K | 1.98% | 16 |
|
|
2021
Q1 | $6.66M | Buy |
30,399
+63
| +0.2% | +$12.6K | 1.99% | 16 |
|
|
2020
Q4 | $5.3M | Buy |
30,336
+77
| +0.3% | +$13.3K | 1.6% | 28 |
|
|
2020
Q3 | $4.89M | Sell |
30,259
-684
| -2% | -$108K | 1.65% | 29 |
|
|
2020
Q2 | $4.42M | Sell |
30,943
-4
| -0% | -$553 | 1.63% | 30 |
|
|
2020
Q1 | $3.36M | Buy |
30,947
+121
| +0.4% | +$17.4K | 1.54% | 37 |
|
|
2019
Q4 | $4.48M | Buy |
30,826
+420
| +1% | +$60.6K | 1.5% | 36 |
|
|
2019
Q3 | $4.39M | Buy |
30,406
+95
| +0.3% | +$13.9K | 1.62% | 36 |
|
|
2019
Q2 | $4.5M | Buy |
30,311
+222
| +0.7% | +$31K | 1.7% | 30 |
|
|
2019
Q1 | $3.96M | Sell |
30,089
-57
| -0.2% | -$7.02K | 1.61% | 32 |
|
|
2018
Q4 | $3.27M | Sell |
30,146
-3,725
| -11% | -$499K | 1.69% | 30 |
|
|
2018
Q3 | $5.05M | Buy |
33,871
+195
| +0.6% | +$29.7K | 1.99% | 18 |
|
|
2018
Q2 | $5.19M | Buy |
33,676
+568
| +2% | +$85.7K | 2.24% | 13 |
|
|
2018
Q1 | $4.6M | Sell |
33,108
-142
| -0.4% | -$20.9K | 2.03% | 16 |
|
|
2017
Q4 | $4.56M | Sell |
33,250
-515
| -2% | -$68.1K | 2.01% | 19 |
|
|
2017
Q3 | $4.38M | Buy |
33,765
+139
| +0.4% | +$18.5K | 1.98% | 22 |
|
|
2017
Q2 | $4.45M | Buy |
33,626
+450
| +1% | +$55.1K | 2.01% | 21 |
|
|
2017
Q1 | $4.09M | Buy |
33,176
+676
| +2% | +$80K | 1.89% | 22 |
|
|
2016
Q4 | $3.58M | Buy |
32,500
+7,910
| +32% | +$879K | 1.79% | 24 |
|
|
2016
Q3 | $2.9M | Buy |
+24,590
| New | +$2.9M | 1.45% | 32 |
|
|
2014
Q2 | – | Sell |
-811
| Closed | -$68K | – | 158 |
|
|
2014
Q1 | $68K | Buy |
+811
| New | +$64.7K | 0.03% | 126 |
|
Other funds holding LH
Carderock Capital Management's LH Position: Q2 2023 in Review
Carderock Capital Management sold out of Labcorp (LH) in Q2 2023, closing a stake of 17,171 shares — an estimated $3.38M sold.
Carderock Capital Management first reported a position in LH in Q1 2014 and held it in 28 quarters. The position peaked at $8.7M in Q4 2021. 933 funds tracked by Wall St. Rank hold LH as of Q2 2023.
- Carderock Capital Management reported no remaining Labcorp position as of Q2 2023 after selling out during the quarter.
- Carderock Capital Management sold 17,171 Labcorp shares in Q2 2023, an estimated $3.38M.
- Carderock Capital Management first reported a position in Labcorp in Q1 2014 and held it in 28 quarters.
- Carderock Capital Management's Labcorp position peaked at $8.7M in Q4 2021.
- 933 funds tracked by Wall St. Rank held Labcorp as of Q2 2023.
Based on Carderock Capital Management's 13F filing for Q2 2023, filed 25 Jul 2023.